Djo, LLC
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$8.3Mgeneral payments (2019-2025)
$62Kresearch payments (2019-2025)
7,092clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
- Donjoy $1.9M associated (2023-2025)
- Procare $1.2M associated (2023-2025)
- Cmf $421K associated (2023-2025)
- Aircast $99K associated (2023-2025)
- Chattanooga $36K associated (2023-2025)
- Dr Comfort $33K associated (2023-2025)
- Lightforce $3,544 associated (2023-2025)
- Raw Material $685 associated (2023-2025)
- Exos $650 associated (2023-2025)
- Compex $187 associated (2023-2025)
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| William Nordt | Richmond, VA | Sports Medicine (Orthopaedic Surgery) | $2,556,021.72 |
| Benjamin Domb | Des Plaines, IL | Sports Medicine (Orthopaedic Surgery) | $1,252,338.50 |
| Thomas Edwards | Houston, TX | Orthopaedic Surgery | $597,485.38 |
| Sumant Krishnan | Dallas, TX | Orthopaedic Surgery | $483,610.14 |
| Stephen Snyder | Van Nuys, CA | Sports Medicine (Orthopaedic Surgery) | $254,965.27 |
| Seth Sherman | Stanford, CA | Sports Medicine (Orthopaedic Surgery) | $81,941.87 |
| Brian Cole | Chicago, IL | Sports Medicine (Orthopaedic Surgery) | $72,650.86 |
| Thomas Myers | Atlanta, GA | Sports Medicine (Orthopaedic Surgery) | $62,841.95 |
| Daniel Cooper | Dallas, TX | Sports Medicine (Orthopaedic Surgery) | $62,793.58 |
| Michael Crovetti | Henderson, NV | Orthopaedic Surgery | $62,680.80 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.